Pancreatic Cancer | Tumor

CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.

Facing Cancer Together: Jim and Melanie’s Patient-Caregiver Story

February 13th 2025, 6:00pm

Article

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's sarcoma diagnosis.

Pelareorep With Chemo and Tecentriq Shows Acceptable Safety in Metastatic PDAC

February 9th 2025, 7:00pm

Article

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma.

Pancreatic Cancer Diagnoses and Mortality Rates Rise

February 4th 2025, 9:32pm

Article

The recent American Cancer Society’s Cancer Statistics, 2025 report was released revealing a sobering trend for pancreatic cancer.

IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer

January 20th 2025, 10:00pm

Article

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.

Cancer Therapies Approved by the FDA in December 2024

January 2nd 2025, 4:00pm

Article

The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.

Top 5 Cancer Vaccine Stories from 2024

December 25th 2024, 3:00pm

Article

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Top FDA Approvals of Oncology Therapies in 2024

December 23rd 2024, 4:00pm

Article

As we near the end of 2024, CURE is looking back at the top FDA approval stories of the year.

FDA Approves Bizengri for Some with NSCLC, Pancreatic Adenocarcinoma

December 4th 2024, 9:05pm

Article

The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.

Phase 3 Study for Advanced Pancreatic Cancer Meets Survival Goal

December 4th 2024, 2:00pm

Article

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields versus chemotherapy.

The Challenge of Finding Out What My Cancer Type Was

November 30th 2024, 7:00pm

Article

Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.